BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11321580)

  • 1. In search of natural substrates and inhibitors of MDR pumps.
    Lewis K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):247-54. PubMed ID: 11321580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial.
    Ball AR; Casadei G; Samosorn S; Bremner JB; Ausubel FM; Moy TI; Lewis K
    ACS Chem Biol; 2006 Oct; 1(9):594-600. PubMed ID: 17168555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.
    Tegos G; Stermitz FR; Lomovskaya O; Lewis K
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3133-41. PubMed ID: 12234835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.
    Stermitz FR; Lorenz P; Tawara JN; Zenewicz LA; Lewis K
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1433-7. PubMed ID: 10677479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of cationic antibacterial agents berberine, palmatine, and benzalkonium through bimolecular planar phospholipid film and Staphylococcus aureus membrane.
    Severina II; Muntyan MS; Lewis K; Skulachev VP
    IUBMB Life; 2001 Dec; 52(6):321-4. PubMed ID: 11895082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V
    Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
    Lomovskaya O; Watkins W
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):225-36. PubMed ID: 11321578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial efflux pump inhibitors from natural sources.
    Stavri M; Piddock LJ; Gibbons S
    J Antimicrob Chemother; 2007 Jun; 59(6):1247-60. PubMed ID: 17145734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery.
    Hsieh PC; Siegel SA; Rogers B; Davis D; Lewis K
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6602-6. PubMed ID: 9618458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin.
    Musumeci R; Speciale A; Costanzo R; Annino A; Ragusa S; Rapisarda A; Pappalardo MS; Iauk L
    Int J Antimicrob Agents; 2003 Jul; 22(1):48-53. PubMed ID: 12842327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions.
    Lewinson O; Adler J; Poelarends GJ; Mazurkiewicz P; Driessen AJ; Bibi E
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1667-72. PubMed ID: 12578981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria.
    Andersen C
    Rev Physiol Biochem Pharmacol; 2003; 147():122-65. PubMed ID: 12783268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
    Lomovskaya O; Bostian KA
    Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MdfA, an interesting model protein for studying multidrug transport.
    Bibi E; Adler J; Lewinson O; Edgar R
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):171-7. PubMed ID: 11321570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
    Poole K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):255-64. PubMed ID: 11321581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria.
    Belofsky G; Percivill D; Lewis K; Tegos GP; Ekart J
    J Nat Prod; 2004 Mar; 67(3):481-4. PubMed ID: 15043439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps.
    Tegos GP; Hamblin MR
    Antimicrob Agents Chemother; 2006 Jan; 50(1):196-203. PubMed ID: 16377686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.